Adaptive Biotechnologies Co. (NASDAQ:ADPT) Forecasted to Post Q3 2023 Earnings of ($0.32) Per Share

Adaptive Biotechnologies Co. (NASDAQ:ADPT – Free Report) – William Blair cut their Q3 2023 EPS estimates for Adaptive Biotechnologies in a research note issued to investors on Tuesday, August 15th. William Blair analyst A. Brackmann now forecasts that the company will post earnings per share of ($0.32) for the quarter, down from their prior forecast […]

Related Keywords

Arizona ,United States ,William Blair ,Piper Sandler ,Morgan Stanley ,Financial Services Group Inc ,Adaptive Biotechnologies Company Profile ,Group Plc ,Adaptive Biotechnologies Co ,Adaptive Biotechnologies Corporation ,Commonwealth Equity Services ,Nasdaq ,Bouvel Investment Partners ,Securities Exchange Commission ,Adaptive Biotechnologies ,Free Report ,Adaptive Biotechnologie ,Get Free Report ,Nitin Sood ,Exchange Commission ,State Retirement System ,Equity Services ,Investment Partners ,General Group Plc ,Services Group ,Biotechnologies Corporation ,Adaptive Biotechnologies Daily ,Nasdaq Adpt ,Adpt ,Medical ,Earnings Estimates ,